Drugs / GSK958108
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00861484 | Nov 2008 → Dec 2009 | premature ejaculation | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00664365 | Apr → Aug 2008 | premature ejaculation | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK958108 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00664365 ↗ |
| Modality | Small molecule | — CHEMBL6068554 ↗ |
| Route | Oral | “GSK958108 oral tablets” NCT00664365 ↗ |